Lacosamide API passed EDQM review
- Categories:Company News
- Time of issue:2021-02-26
- Views:0
(Summary description)February 25, 2021, the Lacosamide (LACOSAMIDE) API of Bjinnianhui67 passed the review of the European Medicines Quality Administration (EDQM) and obtained the CEP certificate.
Beijing Hope is the first company in China to obtain the CEP certificate for the Lacosamide API. The event marks another step towards global market.
Lacosamide API passed EDQM review
(Summary description)February 25, 2021, the Lacosamide (LACOSAMIDE) API of Bjinnianhui67 passed the review of the European Medicines Quality Administration (EDQM) and obtained the CEP certificate.
Beijing Hope is the first company in China to obtain the CEP certificate for the Lacosamide API. The event marks another step towards global market.
- Categories:Company News
- Time of issue:2021-02-26
- Views:0
February 25, 2021, the Lacosamide (LACOSAMIDE) API of Bjinnianhui67 passed the review of the European Medicines Quality Administration (EDQM) and obtained the CEP certificate.
Beijing Hope is the first company in China to obtain the CEP certificate for the Lacosamide API. The event marks another step towards global market.
Scan the QR code to read on your phone
jinnianhui67 滇ICP备19009168号-1
